Načítá se...
L-asparaginase in the treatment of patients with acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) is a hematologic malignancy that predominantly occurs in children between 2 and 10 years of age. L-asparaginase is an integral component of treatment for patients with ALL and since its introduction into pediatric treatment protocols in the 1960s, survival rates in...
Uloženo v:
| Vydáno v: | J Pharmacol Pharmacother |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4936081/ https://ncbi.nlm.nih.gov/pubmed/27440950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.184769 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|